MarketPeel
Insider Trading Intelligence
KP

Kush Parmar

APRE
10% OWNER · APREA THERAPEUTICS, INC. · CIK 0001664281
FILING MIX · LIFETIME36%/64%
BUYS
38
SELLS
69
TOTAL VALUE
$160.17M
COMPANIES
9
ACTIVE SINCE
May 2020
HOLDINGS NOW
7,894,605
AVG SELL PX
$14.93
TRADE KIND
SHOWING 107 / 107
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
46 backtested trades · 8 horizons · 17 pending
Forward-return performance of every backtestable P/S trade by Kush Parmar, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d46+80.43%-4.30%+0.95%-5.25%-5.61%-2.02
14d46+67.39%-3.74%+0.87%-4.61%-4.65%-1.42
30d46+76.09%-2.72%+2.07%-4.79%-12.99%-0.64
60d46+76.09%-11.96%+5.10%-17.06%-21.71%-2.46
90d46+76.09%-20.64%+5.42%-26.06%-29.44%-3.57
180d46+71.74%-31.90%+8.57%-40.47%-55.98%-6.24
1y46(5 pending)+65.85%-41.81%+19.64%-61.46%-59.55%-8.17
2y46(12 pending)+52.94%-40.71%+22.19%-62.90%-72.20%-6.71
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APRE · 138,497 shares · as of Oct 5, 2020
0543,4371,086,8741,630,3112,173,748SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 38 buys / 69 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 10, 2026Jun 12, 2026View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
200,000$8.80$1.76M2,963,066Nov 14, 2025Nov 18, 2025View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
2,941,176$1.53$4.50M2,941,176Sep 11, 2025Sep 15, 2025View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
163,979$3.42$560.8K1,457,064Aug 22, 2025Aug 22, 2025View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
6,470$3.42$22.1K57,493Aug 22, 2025Aug 22, 2025View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
58,642$3.57$209.4K1,621,043Aug 21, 2025Aug 22, 2025View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,314$3.57$8.3K63,963Aug 21, 2025Aug 22, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
20,065$7.50$150.5K3,163,066Jul 9, 2025Jul 11, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,935$7.50$52.0K1,093,313Jul 9, 2025Jul 11, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$7.12$132.3K3,183,131Jul 1, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$7.12$45.7K1,100,248Jul 1, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
18,578$6.81$126.6K3,201,709Jun 30, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
6,422$6.81$43.8K1,106,670Jun 30, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
19,265$6.91$133.1K1,113,092Jun 27, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
55,735$6.91$385.1K3,220,287Jun 27, 2025Jul 1, 2025View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 11, 2025Jun 12, 2025View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
302,770302,770Oct 15, 2024Oct 15, 2024View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
909,090$11.00$10.00M2,625,145Oct 15, 2024Oct 15, 2024View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
4,244,7700Oct 15, 2024Oct 15, 2024View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
15,002,1660Oct 15, 2024Oct 15, 2024View →
CAMP
CAMP4 THERAPEUTICS CORP
SALE
3,395,8160Oct 15, 2024Oct 15, 2024View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASE
1,716,0551,716,055Oct 15, 2024Oct 15, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
2,000$6.06$12.1K1,679,685Sep 13, 2024Sep 13, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
79$6.06$47966,277Sep 13, 2024Sep 13, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
11,758$6.06$71.3K8,167,206Sep 13, 2024Sep 13, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
36,504$6.60$240.9K1,681,685Sep 11, 2024Sep 13, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
214,556$6.60$1.42M8,178,964Sep 11, 2024Sep 13, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
SALE
1,440$6.60$9.5K66,356Sep 11, 2024Sep 13, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
214,6920Jul 22, 2024Jul 24, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
SALE
843,5920Jul 22, 2024Jul 24, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
1,058,2841,058,284Jul 22, 2024Jul 24, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
833,333$12.00$10.00M1,182,054Jul 22, 2024Jul 24, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
348,721$10.20$3.56M348,721Jul 22, 2024Jul 24, 2024View →
ARTV
ARTIVA BIOTHERAPEUTICS, INC.
PURCHASE
112,966$10.20$1.15M1,171,250Jul 22, 2024Jul 24, 2024View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,00016,000Jun 13, 2024Jun 14, 2024View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
16,50016,500May 15, 2024May 17, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASE
450,000$10.00$4.50M8,393,520Mar 13, 2024Mar 15, 2024View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
136,642$14.90$2.04M635,341Feb 14, 2024Feb 16, 2024View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
688,358$14.90$10.26M3,200,634Feb 14, 2024Feb 16, 2024View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
417,187$15.00$6.26M3,888,992Jan 31, 2024Feb 2, 2024View →
SKYE
SKYE BIOSCIENCE, INC.
PURCHASE
5,206,074$2.31$12.03M7,943,520Jan 31, 2024Feb 2, 2024View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
82,813$15.00$1.24M771,983Jan 31, 2024Feb 2, 2024View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
27,118$1.77$48.0K27,118Jan 2, 2024Jan 4, 2024View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
32,711$15.00$490.7K854,796Sep 26, 2023Sep 28, 2023View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
164,789$15.00$2.47M4,306,179Sep 26, 2023Sep 28, 2023View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
367,124$16.00$5.87M4,470,968Aug 24, 2023Aug 28, 2023View →
ELVN
ENLIVEN THERAPEUTICS, INC.
SALE
72,876$16.00$1.17M887,507Aug 24, 2023Aug 28, 2023View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,00016,000Jun 8, 2023Jun 12, 2023View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
15,49015,490May 17, 2023May 19, 2023View →
RLYB
RALLYBIO CORP
SALE
100,000$8.20$820.0K2,378,969Mar 7, 2023Mar 9, 2023View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
10,34410,344Jan 3, 2023Jan 5, 2023View →
VOR
VOR BIOPHARMA INC.
PURCHASEGRANT
Stock grant
16,91116,911Jun 14, 2022Jun 16, 2022View →
RLYB
RALLYBIO CORP
SALE
99,671$12.50$1.25M2,478,969Jun 3, 2022Jun 7, 2022View →
RLYB
RALLYBIO CORP
SALE
50,329$12.50$629.1K1,251,755Jun 3, 2022Jun 7, 2022View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,91811,918Jun 2, 2022Jun 6, 2022View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
13,44013,440May 24, 2022May 26, 2022View →
RLYB
RALLYBIO CORP
SALE
33,553$13.00$436.2K1,302,084May 23, 2022May 25, 2022View →
RLYB
RALLYBIO CORP
SALE
66,447$13.00$863.8K2,578,640May 23, 2022May 25, 2022View →
RLYB
RALLYBIO CORP
SALE
139,539$13.05$1.82M2,645,087Feb 8, 2022Feb 10, 2022View →
RLYB
RALLYBIO CORP
SALE
70,461$13.05$919.5K1,335,637Feb 8, 2022Feb 10, 2022View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
5,7725,772Jan 3, 2022Jan 5, 2022View →
VOR
VOR BIOPHARMA INC.
SALE
91,836$15.30$1.41M1,766,634Nov 16, 2021Nov 18, 2021View →
VOR
VOR BIOPHARMA INC.
SALE
238,870$15.30$3.65M4,595,089Nov 16, 2021Nov 18, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,140882,357Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
318,1400Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
2,371,7390Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
318,6160Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
564,217564,217Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
250,000$20.00$5.00M1,132,357Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
564,2170Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
318,616649,771Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
2,371,7393,021,510Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
SALE
254,5120Nov 2, 2021Nov 5, 2021View →
TRDA
ENTRADA THERAPEUTICS, INC.
PURCHASE
254,5123,276,022Nov 2, 2021Nov 5, 2021View →
CABA
CABALETTA BIO, INC.
SALE
258,456$13.00$3.36M1,731,119Nov 1, 2021Nov 3, 2021View →
CABA
CABALETTA BIO, INC.
SALE
36,544$13.00$475.1K333,144Nov 1, 2021Nov 3, 2021View →
CABA
CABALETTA BIO, INC.
SALE
625,000$9.70$6.06M1,989,575Sep 7, 2021Sep 9, 2021View →
RLYB
RALLYBIO CORP
PURCHASE
615,384$13.00$8.00M1,406,098Aug 2, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
PURCHASEGRANT
Stock grant
13,44013,440Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
SALE
1,795,9460Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
SALE
8,742,6540Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
SALE
7,192,7950Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
PURCHASE
790,714790,714Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
SALE
5,034,9550Jul 28, 2021Aug 4, 2021View →
RLYB
RALLYBIO CORP
PURCHASE
2,784,6262,784,626Jul 28, 2021Aug 4, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASE
1,414,0264,722,848Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASE
1,414,0261,414,026Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASE
3,308,8223,308,822Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
SALE
19,230,7680Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
SALE
45,000,0000Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASE
444,444$18.00$8.00M1,858,470Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASE
111,111$18.00$2.00M4,833,959Feb 9, 2021Feb 9, 2021View →
VOR
VOR BIOPHARMA INC.
PURCHASEGRANT
Stock grant
16,90016,900Feb 5, 2021Feb 9, 2021View →
CABA
CABALETTA BIO, INC.
SALE
10,530$13.00$136.9K369,688Jan 12, 2021Jan 12, 2021View →
CABA
CABALETTA BIO, INC.
SALE
74,470$13.00$968.1K2,614,575Jan 12, 2021Jan 12, 2021View →
CABA
CABALETTA BIO, INC.
SALE
37,411$13.00$486.3K380,218Jan 8, 2021Jan 12, 2021View →
CABA
CABALETTA BIO, INC.
SALE
264,589$13.00$3.44M2,689,045Jan 8, 2021Jan 12, 2021View →
CABA
CABALETTA BIO, INC.
SALE
36,916$14.75$544.5K417,629Dec 10, 2020Dec 14, 2020View →
CABA
CABALETTA BIO, INC.
SALE
261,084$14.75$3.85M2,953,634Dec 10, 2020Dec 14, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
175,000$25.30$4.43M138,497Oct 5, 2020Oct 7, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
19,836$33.30$660.5K313,497Jun 16, 2020Jun 18, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
115,357$33.30$3.84M1,823,192Jun 16, 2020Jun 18, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
4,807$33.30$160.1K75,965Jun 16, 2020Jun 18, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
235,200$28.75$6.76M1,938,549Jun 11, 2020Jun 15, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
9,800$28.75$281.8K80,772Jun 11, 2020Jun 15, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
10,200$35.15$358.5K90,572May 19, 2020May 21, 2020View →
APRE
APREA THERAPEUTICS, INC.
SALE
244,800$35.15$8.60M2,173,748May 19, 2020May 21, 2020View →
Other insiders · APRE
Loading peer insiders…
About this filer
CIK 0001664281
ROLE
10% Owner
PRIMARY
APRE
COMPANIES
9
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001664281DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback